- 不限
- 2023-08-24 [星期四]
- 2023-08-25 [星期五]
- 2023-12-21 [星期四]
- 不限
- 705 庐山厅
- Asia Pacific Tower Meeting Room 3
- Asia Pacific Tower Fraternity Hall
- Asia Pacific Tower Presence Chamber
- 705庐山
2023-08-25 星期五
Asia Pacific Tower Fraternity Hall
| 编号 | 时间 | 题目 | 讲者 | 单位 |
|---|---|---|---|---|
| 1 | 08:30-08:40 |
Opening Remarks
Gao-Jun Teng
Zhongda Hospital, Southeast University, China
|
||
| 2 | 08:40-09:00 |
Interventional devices for the treatment of obesity |
Ho-Young Song | Asan Medical Center, University of Ulsan College of Medicine, Korea |
| 3 | 09:00-09:20 |
Interventional molecular imaging: Recent advance |
Xiaoming Yang | University of Washington School of Medicine, USA |
| 4 | 09:20-09:40 |
Publishing with Lancet journals |
Hugh Thomas | The Lancet Gastroenterology & Hepatology |
| 5 | 09:40-10:00 |
Endovascular denervation for type 2 diabetes mellitus: from bench to bedside |
Gao-Jun Teng | Zhongda Hospital, Southeast University, China |
| 6 | 10:00-10:20 |
Pannel Discussion |
||
| 7 | 10:20-10:30 |
Coffee Break |
||
| 编号 | 时间 | 题目 | 讲者 | 单位 |
|---|---|---|---|---|
| 1 | 10:30-10:50 |
Recent update of plug-assisted retrograde transvenous obliteration (PARTO) |
Hyun-Ki Yoon | Asan Medical Center, University of Ulsan College of Medicine |
| 2 | 10:50-11:10 |
MRI-guided irreversible electroporation combined with engineered NK cell immunotherapy for liver tumors |
Zhuo-Li Zhang | University of California, USA |
| 3 | 11:10-11:30 |
Ablation-Osteoplasty-Reinforcement-Internal Fixation (AORIF), a Skeletal Interventional Oncology Procedure, is the First-Line Treatment for Osteolytic Periacertabular Metastases: An Orthopaedic Oncologist’s Perspective |
Francis Y. Lee | Yale School of Medicine, USA |
| 4 | 11:30-11:50 |
Ethanol sclerotherapy for endometrioma |
Ji Hoon Shin | Asan Medical Cente, University of Ulsan College of Medicine, Korea |
| 5 | 11:50-12:10 |
Pannel Discussion |
||
| 编号 | 时间 | 题目 | 讲者 | 单位 |
|---|---|---|---|---|
| 1 | 14:00-14:20 |
Yttrium-90 (Y90) SIRT in HCC: practical applications and evidence |
David M. Liu | Vancouver General Hospital, Canada |
| 2 | 14:20-14:40 |
Science hehind the dosimetry of yttrium-90 (Y90) |
Zhong Qian | Louisiana State University, USA |
| 3 | 14:40-15:00 |
Using SIRT to cure the incurable |
David M. Liu | Vancouver General Hospital, Canada |
| 4 | 15:00-15:30 |
Discussion
Ye-Fa Yang
The Third Affiliated Hospital of Naval Medical University, China /
Hai-Peng Yu
Tianjin Medical University Cancer Institute & Hospital, China /
Lin Zhang
Beijing Tsinghua Changgung Hospital, China /
Kang-Shun Zhu
The Second Affiliated Hospital of Guangzhou Medical University, China
|
||
| 5 | 15:30-15:40 |
Coffee Break |
||
| 编号 | 时间 | 题目 | 讲者 | 单位 |
|---|---|---|---|---|
| 1 | 15:40-16:00 |
TACE refractoriness: CCI definition and consensus statement |
Bin-Yan Zhong | Zhejiang Cancer Hospital, China |
| 2 | 16:00-16:20 |
TACE plus ablation for HCC: the interventional approch |
jian wang | Peking University First Hospital |
| 3 | 16:20-16:40 |
Surgical ligation versus endovascular embolization for type II congenital extrahepatic portosystemic shunt |
Feng Duan | PLA General Hospital, China |
| 4 | 16:40-17:00 |
Current research status of unresectable HCC with portal hypertension in China |
Fei Gao | Sun Yat-Sen University Cancer Center, China |
| 5 | 17:00-17:20 |
TBD |
Jie Kong | Nanjing First Hospital, Nanjing Medical University |
| 6 | 17:20-17:50 |
Discussion
Qi Zhang
Zhongda Hospital, Southeast University, China /
Wei-Zhong Zhou
The first affiliated hospital of Nanjing medical university, China /
Qianxin Huang
|
||
| 7 | 17:50-18:00 |
Wrap-up |
||
